Dimerix (ASX:DXB) Common Stock: A$91.18 Mil (As of Dec. 2025)


ASX:DXB Dimerix Ltd ASX:DXB
32 GF Score
Price A$0.21
! 3 Warning Signs
View Full Analysis

What is Dimerix Common Stock?

Dimerix ASX:DXB +10.53% 32 Common Stock is A$91.18 Mil as of Dec. 2025. GuruFocus rates ASX:DXB with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Dimerix's quarterly common stock increased from Dec. 2024 (A$84.67 Mil) to Jun. 2025 (A$90.93 Mil) and increased from Jun. 2025 (A$90.93 Mil) to Dec. 2025 (A$91.18 Mil).

Dimerix's annual common stock increased from Jun. 2023 (A$55.49 Mil) to Jun. 2024 (A$83.38 Mil) and increased from Jun. 2024 (A$83.38 Mil) to Jun. 2025 (A$90.93 Mil).

Dimerix Common Stock Historical Data

* Premium members only.

The historical data trend for Dimerix's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimerix Common Stock Chart

Dimerix Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.39 50.90 55.49 83.38 90.93

Dimerix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.88 83.38 84.67 90.93 91.18
ASX:DXB
32GF Score
Dimerix Ltd ASX:DXB
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimerix Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$91.18 Mil mean?
Dimerix (ASX:DXB) has a Common Stock of A$91.18 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Dimerix and its competitors.
Is Dimerix's Common Stock too high?
Dimerix's current Common Stock is A$91.18 Mil. Overall, Dimerix has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Dimerix's Common Stock compare to VRTX and REGN?
Dimerix's Common Stock of A$91.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Dimerix and its competitors. Dimerix's current Common Stock is A$91.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimerix stock overvalued right now?
Dimerix (ASX:DXB) has a current Common Stock of A$91.18 Mil. The current Common Stock is A$91.18 Mil. Dimerix's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Dimerix (ASX:DXB), the current Common Stock is A$91.18 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dimerix Business Description

Address 425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.
32GF Score

Get the complete analysis for ASX:DXB

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.21
Price